Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2017.164 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis |
Dr. HUI Aric Josun 許祖紳 |
| 2017.531 | A Phase 2, Open-label Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) from Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) in Virologically Suppressed Chronic Hepatitis B Subjects with Renal and/or Hepatic Impairment |
Dr. HUI Aric Josun 許祖紳醫生 |
| 2017.165 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) |
Dr. HUI Aric Josun 許祖紳 |
| 2010.464 | Dose-Ranging Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Pegylated Interferon Lambda (BMS-914143) Monotherapy in Interferon-Naive Patients with Chronic Hepatitis B Virus Infection who are HBeAg-positive | Dr HUI Aric Josun |
| 2011.180 | A randomized, double-blind, placebo-controlled trial of the efficacy and safety of DEB025/Alisporivir in combination with peg-IFN | Dr. Hui Aric Josun |
| 2013.117 | An Open Label, Phase 2a, Single-Arm Study of the Antifibrotic Activity of FG-3019 in Subjects with Advanced Liver Fibrosis due to Chronic Hepatitis C Infection (HCV) | Dr. Hui Aric Josun |
| 2010.530 | A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of FG-3019 in Subjects with Liver Fibrosis due to Chronic Hepatitis B Infection | Dr. HUI Aric Josun |
| 2011.527 | Safety & Effectiveness of Nurse Performed Colonoscopies under Supervision: A Randomized Controlled Study in Asia (NE Study) | DR HUI ARIC JOSUN |
| 2012.277 | A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combination with Ribavirin, in the Treatment of Na_ve Genotype 2 and 3 Chronic Hepatitis C Subjects | Dr Hui Aric Josun |
| 2011.225 | A Phase 4, Randomized, Open-label, Active-Controlled, Superiority Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination with Peginterferon α-2a (Pegasys®) versus Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Non-Cirrhotic Subjects with HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B (CHB) | Dr. Hui Aric Josun |
| 2012.101 | A Structured Nurse-led Clinic after Open Access Endoscopy for Patients with Functional Dyspepsia: A Randomized Controlled Study | Dr. HUI Aric Josun |
| 2012.539 | An open-label trial of 48-week peginterferon alfa-2a (PGEASYS) to assess the sustained response of chroinc hepatitis B patients with HBeAg seroconversion on nucleot(s)ide analogue therapy | Dr. HUI Aric Josun |
| 2012.352 | A multi-centre long-term follow-up study to assess the durability of sustained virologic response in alisporivir-treated chronic Hepatitis C patients | Dr. HUI Aric Josun |
| 2012.550 | A multicenter open-label study to evaluate the safety and efficacy of PEG-Intron™ versus PEGASYS™ in subjects with HBeAg positive chronic hepatitis B and HBeAg negative chronic hepatitis B | Dr. HUI Aric Josun |
| 2012.350 | A multi-centre 3-year follow-up study to assess the viral activity in patients who failed to achieve sustained virologic response in Novartis-sponsored Alisporivir-studies for chronic Hepatitis C patients | Dr. HUI Aric Josun |
| 2009.354 | A pharmacokinetic/pharmacodynamic evaluation of ABF656 in subjects with chronic hepatitis B, eAg+, infection | Dr. Hui Aric Josun |
| 2019.067 | The influence of emotion regulation on physiological changes in couple conflict discussion |
Dr. HUI Chin Ming 許展明 |
| 2019.066 | Spousal coordination across transition to parenthood: Its prenatal antecedents and links with health and relationship well-being |
Dr. HUI Chin Ming 許展明 |
| 2020.012 | Spousal coordination across transition to parenthood: Its associations with physical and psychological well-being |
Dr. HUI Chin Ming 許展明 |
| 2014.673 | A crossover study to compare the filtration factor and tolerability of a novel non-fit-tested HEPA filtering facemask with a fit-tested N95 mask | Dr. HUI Constance Yung Ting |
| 2009.137 | A Randomized Controlled Study of the Effects of CPAP on Erythrocyte Adhesiveness/ Aggregation and Coagulability in Obstructive Sleep Apnoea Syndrome | Prof. Hui David |
| 2009.451 | A Pilot Phase 2, Open-Label, Randomized Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult Hospitalized Subjects with Confirmed Pandemic H1N1 Influenza Infection | Prof. Hui David |
| 2010.177 | To Study the effects of COPD and the Overlap Syndrome on systemic inflammatory markers | Prof. HUI David |
| 2011.005 | Validation of the new COPD Assessment Test (CAT) translated into Chinese in patients with Chronic Obstructuve Pulmonary Disease (COPD) | Prof. Hui David S.C. |
| 2014.345 | Obstructive sleep apnoea and CPAP treatment response in patients with non-alcoholic fatty liver disease | Prof. HUI David S.C. |
| 2014.417 | A phase III, 52 week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, all administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease | Prof. HUI David Shu Cheong |
| 2017.238 | A prospective, epidemiological, multi-country, cohort study to assess the occurrence of potential bacterial and viral pathogens in stable chronic obstructive pulmonary disease (COPD) and during acute exacerbations of COPD (AECOPD), in moderate to very severe COPD patients, in Asia Pacific. |
Prof. HUI David Shu Cheong 許樹昌 |
| 2014.640 | A randomised, double-blind, active-controlled parallel group study to evaluate the effect of 52 weeks of once daily treatment of orally inhaled tiotropium + olodaterol fixed dose combination compared with tiotropium on Chronic Obstructive Pulmonary Disease (COPD) exacerbation in patients with severe to very severe COPD. | Prof. HUI David Shu Cheong |
| 2014.334 | Randomized, double-blind, placebo-controlled, multicenter study comparing Ciprofloxacin DPI 32.5 mg BID intermittently administered for 28 days on / 28 days off or 14 days on / 14 days off versus placebo to evaluate the time to first pulmonary exacerbation and frequency of exacerbations in subjects with non-cystic fibrosis bronchiectasis | Prof. HUI David Shu Cheong |
| 2016.096 | A Phase IIIB, non-randomized, open-label, multi-country, multi-centric cross-vaccination study to evaluate the safety of GSK Biologicals' Herpes Zoster subunit (HZ/su) vaccine when administered intramuscularly on a two-dose schedule to subjects who previously received placebo in ZOSTER-006 and ZOSTER-022 studies. |
Prof. HUI David Shu Cheong 許樹昌 |
| 2014.319 | An observer-blind study to evaluate the safety and immunogenicity of GSK Biologicals’ influenza vaccine(s) GSK3277510A and GSK3277509A administered in adults 18 to 60 years of age. | Prof. HUI David Shu Cheong |
| 2016.191 | A phase IIIb, open-label, multi-country, multi-centre, long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogenicity persistence of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine and assessment of 1 or 2 additional doses on a 0 or 0, 2-month schedule in two subgroups of older adults. |
Prof. HUI David Shu Cheong 許樹昌 |
| 2007.072 | Management and Clinical Progress of Patients with Severe Influenza - A Prospective Observational Study | Prof. HUI David Shu Cheong |
| 2011.214 | The effects of CPAP on twist mechanics of the left ventricle in patients with moderate to severe Obstructive Sleep Apnoea | Prof. Hui David Shu Cheong |
| 2021.032 | A PHASE III OPEN LABEL EXTENSION STUDY TO EVALUATE LONG TERM SAFETY AND EFFICACY OF PRM 151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) |
Prof. HUI David Shu Cheong 許樹昌教授 |
| 2022.646 | Early Prednisolone for Suspected Community-acquired Acute Respiratory Tract Infection (PREDICATE): A Double-blind, Randomised, Multi-centre, Adaptive Platform, Controlled Trial | Prof. HUI David Shu Cheong |
| 2021.298 | Prevalence of non-alcoholic fatty liver disease among non-obese obstructive sleep apnea by using transient elastography | Prof. HUI David Shu Cheong |
| 2020.508 | Clinical Characteristics of COPD Patients in Hong Kong – An analysis of the Prince of Wales Hospital COPD patients |
Prof. HUI David Shu Cheong 許樹昌教授 |
| 2022.407 | A phase 3b, open-label, multi-country, multi-centre, long-term follow-up study of ZOSTER-049 (follow- up of ZOSTER-006/022 studies) to assess the prophylactic efficacy, safety and persistence of immune response of a Herpes Zoster subunit vaccine and assessment of persistence of immune response and safety of 1 or 2 additional doses administered in ZOSTER-049 in 2 subgroups of older adults. | Prof. HUI David Shu Cheong |
| 2022.412 | Study on Clinical Use of EVUSHELD (AZD7442) in the Real-world Setting – A Multicentre, Single-arm, Observational Study to Determine the Utilisation and Clinical Outcomes of EVUSHELD in China |
Prof. HUI David Shu Cheong 許樹昌教授 |
| 2010.331 | A randomized controlled study to examine the effect of lifestyle modification program in obstructive sleep apnea patients | Prof. Hui David Shu Cheong |
| 2010.605 | A 6-month, double-blind, randomised, multicenter, multinational trial to investigate the effect of 500 | Professor Hui David Shu Cheong |
| 2011.470 | A Phase III, Randomized, Double-blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate Compared with Aclidinium Bromide, Formoterol Fumarate and Placebo for 24 Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) | Professor Hui David Shu Cheong |
| 2013.213 | A 52-week treatment, multi-center, randomized, double-blind, double dummy, parallel-group, active controlled study to compare the effect of QVA149 (indacaterol maleate / glycopyrronium bromide) with salmeterol/fluticasone on the rate of exacerbations in subjects with moderate to very severe COPD | Prof. HUI David Shu Cheong |
| 2009.544 | Clinical Bioequivalence Study on Two Salbutamol Formulations | Prof. Hui David Shu Cheong |
| 2012.415 | A randomized, double-blind, 12-week treatment, parallel-group study to evaluate the efficacy and safety of QMF149 (150 _g/160 _g o.d.) compared with salmeterol xinafoate/fluticasone propionate (50 _g/500 _g b.i.d.) in patients with chronic obstructive pulmonary disease | Prof. Hui David Shu Cheong |
| 2010.267 | A phase III, randomized, observer-blind, placebo-controlled, multicentre, clinical vaccination trial to assess the prophylactic efficacy, safety and immunogenicity of GSK Biologicals’ gE/AS01B vaccine when administered intramuscularly on a 0, 2-month schedule in adults aged 70 years and older | Prof. HUI David Shu Cheong |
| 2010.266 | A phase III, randomized, observer-blind, placebo-controlled, multicentre, clinical vaccination trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals’ gE/AS01B vaccine when administered intramuscularly on a 0, 2-month schedule in adults aged 50 years and older | Prof. HUI David Shu Cheong |
| 2011.312 | Ethnic and Gender Comparison of Craniofacial Phenotypes in Obstructive Sleep Apnoea | Prof. Hui David Shu Cheong |
| 2008.286 | A Randomized, Parallel, Controlled Study to Evaluate the Role of Pretreatment Drug Susceptibility Tests in the Selection of Regimens of Chemotherapy for Retreatment of Relapsed Pulmonary TB in Guangzhou | Prof Hui David Shu Cheong |
Page 107 of 289.